Arm 1 (educational video) for Colorectal Carcinoma (CRC)

Phase-Based Progress Estimates
Fred Hutch/University of Washington Cancer Consortium, Seattle, WA
Colorectal Carcinoma (CRC)+1 More
Media Intervention - Other
All Sexes
What conditions do you have?

Study Summary

This clinical trial compares an educational video intervention versus usual care of no video intervention in decreasing patient fear of a colonoscopy procedure after receiving a positive fecal immunochemical test (FIT). The lack of a follow-up colonoscopy after an abnormal FIT result is associated with an increased risk of colorectal cancer mortality, advanced-stage colorectal cancer, among other complications, compared to the completion of a follow-up colonoscopy. An educational video may reduce patient fear and increase knowledge, self-efficacy, and intent to complete a colonoscopy compared to the usual care of no video intervention.

Eligible Conditions

  • Colorectal Carcinoma (CRC)

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

8 Primary · 1 Secondary · Reporting Duration: Up to 12 months post-abnormal FIT result

Month 6
Incidence of completed colonoscopies
Month 12
Acceptability of the video intervention assessed by a survey
Feasibility: number of contacts needed to reach target enrollment
Feasibility: time to reach recruitment
Incidence of fear related to colonoscopy
Intent to complete a colonoscopy
Knowledge about colonoscopy
Self-efficacy related to colonoscopy
Month 12
Feasibility as measured by study accrual

Trial Safety

Safety Progress

1 of 3

Trial Design

2 Treatment Groups

Arm 2 (usual care)
1 of 2
Arm 1 (educational video)
1 of 2
Active Control
Experimental Treatment

60 Total Participants · 2 Treatment Groups

Primary Treatment: Arm 1 (educational video) · No Placebo Group · N/A

Arm 1 (educational video)Experimental Group · 2 Interventions: Media Intervention, Questionnaire Administration · Intervention Types: Other, Other
Arm 2 (usual care)ActiveComparator Group · 2 Interventions: Best Practice, Questionnaire Administration · Intervention Types: Other, Other

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: up to 12 months post-abnormal fit result
Closest Location: Fred Hutch/University of Washington Cancer Consortium · Seattle, WA
Photo of Seattle  1Photo of Seattle  2Photo of Seattle  3
2018First Recorded Clinical Trial
5 TrialsResearching Colorectal Carcinoma (CRC)
140 CompletedClinical Trials

Eligibility Criteria

Age 18+ · All Participants · 5 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You are able to communicate in English due to initial videos being available in English.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.